Release Details

The Presentation Will Be Webcast Tuesday, May 4, 2004

SAN DIEGO, May 3 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at the Deutsche Bank Securities 29th Annual Health Care Conference tomorrow, Tuesday, May 4, 2004 at 9:30 AM Eastern Daylight Time (EDT) and 6:30 AM Pacific Daylight Time (PDT). The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com.

Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will present a brief overview of the Company highlighting indiplon, the Company's late stage clinical development program for the treatment of insomnia.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will become available approximately one hour after the live webcast concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Tuesday, May 18, 2004.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.